Skip to main content
. 2014 Mar 10;44(4):1007–1034. doi: 10.1590/s1517-83822013000400002

Figure 5.

Figure 5

Retention time averages of new molecules according to the pathological area, which were obtained from 2003 to 2007; * The anti-infective category excludes AIDS antiviral agents (which are in their category). Reproduced from Clinical Pharmacology & Therapeutics, February 2010, Vol. 87, Pages 356–361 with permission of Nature Publishing Group Ltd. (Kaitin, 2010).